These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30694417)

  • 1. Do patients consider computer-adaptive measures more appropriate than static questionnaires?
    Gamper EM; Martini C; Petersen MA; Virgolini I; Holzner B; Giesinger JM
    J Patient Rep Outcomes; 2019 Jan; 3(1):7. PubMed ID: 30694417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire.
    Petersen MA; Aaronson NK; Arraras JI; Chie WC; Conroy T; Costantini A; Dirven L; Fayers P; Gamper EM; Giesinger JM; Habets EJJ; Hammerlid E; Helbostad J; Hjermstad MJ; Holzner B; Johnson C; Kemmler G; King MT; Kaasa S; Loge JH; Reijneveld JC; Singer S; Taphoorn MJB; Thamsborg LH; Tomaszewski KA; Velikova G; Verdonck-de Leeuw IM; Young T; Groenvold M;
    Eur J Cancer; 2018 Sep; 100():8-16. PubMed ID: 29936066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International validation of the EORTC CAT Core: a new adaptive instrument for measuring core quality of life domains in cancer.
    Petersen MA; Aaronson NK; Conroy T; Costantini A; Giesinger JM; Hammerlid E; Holzner B; Johnson CD; Kieffer JM; van Leeuwen M; Nolte S; Ramage JK; Tomaszewski KA; Waldmann A; Young T; Zotti P; Groenvold M;
    Qual Life Res; 2020 May; 29(5):1405-1417. PubMed ID: 31955374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning.
    Petersen MA; Groenvold M; Aaronson NK; Chie WC; Conroy T; Costantini A; Fayers P; Helbostad J; Holzner B; Kaasa S; Singer S; Velikova G; Young T;
    Eur J Cancer; 2010 May; 46(8):1352-8. PubMed ID: 20231085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of standard computerised adaptive test (CAT) settings for the EORTC CAT Core.
    Petersen MA; Vachon H; Giesinger JM; Groenvold M;
    Qual Life Res; 2024 Apr; 33(4):951-961. PubMed ID: 38231438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric evaluation of an item bank for computerized adaptive testing of the EORTC QLQ-C30 cognitive functioning dimension in cancer patients.
    Dirven L; Groenvold M; Taphoorn MJB; Conroy T; Tomaszewski KA; Young T; Petersen MA;
    Qual Life Res; 2017 Nov; 26(11):2919-2929. PubMed ID: 28707048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An emotional functioning item bank of 24 items for computerized adaptive testing (CAT) was established.
    Petersen MA; Gamper EM; Costantini A; Giesinger JM; Holzner B; Johnson C; Sztankay M; Young T; Groenvold M;
    J Clin Epidemiol; 2016 Feb; 70():90-100. PubMed ID: 26363341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
    Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
    Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain.
    Giesinger JM; Kuijpers W; Young T; Tomaszewski KA; Friend E; Zabernigg A; Holzner B; Aaronson NK
    Health Qual Life Outcomes; 2016 Jun; 14():87. PubMed ID: 27267486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an item bank for computerized adaptive test (CAT) measurement of pain.
    Petersen MA; Aaronson NK; Chie WC; Conroy T; Costantini A; Hammerlid E; Hjermstad MJ; Kaasa S; Loge JH; Velikova G; Young T; Groenvold M
    Qual Life Res; 2016 Jan; 25(1):1-11. PubMed ID: 26267524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30.
    Regnault A; Pompilus F; Ciesluk A; Mazerolle F; Bejar R; Fram RJ; Faller DV; Marquis P; Bell JA
    J Patient Rep Outcomes; 2021 Jul; 5(1):60. PubMed ID: 34283303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EORTC computer-adaptive tests measuring physical functioning and fatigue exhibited high levels of measurement precision and efficiency.
    Petersen MA; Aaronson NK; Arraras JI; Chie WC; Conroy T; Costantini A; Giesinger JM; Holzner B; King MT; Singer S; Velikova G; Verdonck-de Leeuw IM; Young T; Groenvold M;
    J Clin Epidemiol; 2013 Mar; 66(3):330-9. PubMed ID: 23347855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brazilian Validation of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) Computerised Adaptive Tests (CAT) Core.
    Marta GN; de Souza TYT; Silva ARNSE; Pereira APA; Ferreira Neto DR; Asso RN; Degrande FAM; Nader-Marta G; da Silva MF; Gadia R; Hanna SA; Holzner B; Saad ED; Petersen MA
    Curr Oncol; 2021 Aug; 28(5):3373-3383. PubMed ID: 34590597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equipercentile equating of scores from common patient-reported outcome measures of physical function in patients with cancer.
    Rothmund M; Pilz MJ; Schlosser L; Arraras JI; Groenvold M; Holzner B; van Leeuwen M; Petersen MA; Schmidt H; Young T; Rose M; Cella D; Giesinger JM;
    J Clin Epidemiol; 2024 Jan; 165():111203. PubMed ID: 37918641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the European Norm for the health-related quality of life domains of the computer-adaptive test EORTC CAT Core.
    Liegl G; Petersen MA; Groenvold M; Aaronson NK; Costantini A; Fayers PM; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M; Nolte S;
    Eur J Cancer; 2019 Jan; 107():133-141. PubMed ID: 30576969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients.
    Mol L; Ottevanger PB; Koopman M; Punt CJ
    Eur J Cancer; 2016 Oct; 66():138-43. PubMed ID: 27573427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thresholds for clinical importance were defined for the European Organisation for Research and Treatment of Cancer Computer Adaptive Testing Core-an adaptive measure of core quality of life domains in oncology clinical practice and research.
    Giesinger JM; Loth FLC; Aaronson NK; Arraras JI; Caocci G; Efficace F; Groenvold M; van Leeuwen M; Petersen MA; Ramage J; Tomaszewski KA; Young T; Holzner B;
    J Clin Epidemiol; 2020 Jan; 117():117-125. PubMed ID: 31593797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies.
    Sommer K; Cottone F; Aaronson NK; Fayers P; Fazi P; Rosti G; Angelucci E; Gaidano G; Venditti A; Voso MT; Baccarani M; Vignetti M; Efficace F
    Qual Life Res; 2020 Mar; 29(3):815-823. PubMed ID: 31782016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.